BIO-TECHNE Corp — insider transactions

9 transactions on record · TECH · CIK 842023

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
9
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$10.4M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$3.7M
2026-07-29
Director share, 12m
33.3%
of transactions where role is stated
Current run
9 sells
consecutive same-direction transactions
Net 3m flow
-$10.4M
purchases minus sales
Total on record
9

Transactions

9 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-312026-07-292Hippel JamesCFOExercise of derivative62,068$47.60$3Mfiling
2026-07-312026-07-292Hippel JamesCFOExercise of derivative62,068$0.00filing
2026-07-312026-07-292Hippel JamesCFOShares withheld for tax51,024$72.03$3.7Mfiling
2026-07-302026-07-282Kelderman KimDirector, Chief Executive OfficerExercise of derivative35,000$47.60$1.7Mfiling
2026-07-302026-07-282Kelderman KimDirector, Chief Executive OfficerShares withheld for tax28,686$72.07$2.1Mfiling
2026-07-302026-07-282Kelderman KimDirector, Chief Executive OfficerExercise of derivative35,000$0.00filing
2026-07-272026-07-234Bohnen ShaneSVP - General CounselExercise of derivative448$47.60$21.3Kfiling
2026-07-272026-07-234Bohnen ShaneSVP - General CounselExercise of derivative448$0.00filing
2026-07-272026-07-234Bohnen ShaneSVP - General CounselShares withheld for tax344$71.77$24.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

BIO-TECHNE Corp insider transactions — 9 filings on record — Tapewire